Most of the tumor tissues were positive for PCP4/PEP19 irrespective of hormone receptor status, indicating that PCP4/PEP19 may present an attractive and alternative therapeutic target in breast cancer, especially in hormone-independent breast cancers. The gene discussed is PCP4; the disease is neoplasm.